Feedback

A Soft Skin Adhesive (SSA) Patch for Extended Release of Pirfenidone in Burn Wounds

Affiliation
Combat Wound Care Group, US Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX 78234, USA
Chung, Eugene P.;
Affiliation
Combat Wound Care Group, US Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX 78234, USA
Nguyen, Jesse Q.;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Tellkamp-Schehr, Tobias;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Goebel, Katja;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Ollek, Anita;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Krein, Cliff;
Affiliation
Combat Wound Care Group, US Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX 78234, USA
Wells, Adrienne R.;
Affiliation
Combat Wound Care Group, US Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX 78234, USA
Sebastian, Eliza A.;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Goebel, Anja;
Affiliation
Labtec GmbH, Raiffeisenstrasse 4, 40764 Langenfeld, Germany(A.O.);(C.K.);(S.N.)
Niese, Svenja;
Affiliation
Combat Wound Care Group, US Army Institute of Surgical Research, JBSA, Fort Sam Houston, TX 78234, USA
Leung, Kai P.

As much as half or more of deep partial-thickness burn wounds develop hypertrophic scarring and contracture. Once formed, treatments are only minimally effective. Pirfenidone (Pf), indicated for treatment of idiopathic pulmonary fibrosis, is an anti-inflammatory and anti-fibrotic small molecule that potentially can be repurposed as a preventative against scarring in burn wounds. We present a drug-in-matrix patch with a soft skin adhesive (SSA) wound-contacting layer for multi-day drug delivery of Pf into burn wounds at the point of injury. Our patch construction consists of an SSA adhesive layer (Liveo™ MG7-9850, Dupont, Wilmington, DE, USA) for wound fixation, an acrylic co-polymer drug matrix (DURO-TAK 87-2852, Henkel, Düsseldorf, Germany) as the drug (Pf) reservoir, and an outermost protective polyurethane backing. By employing a drug-in-matrix patch design, Pf can be loaded as high as 2 mg/cm 2 . Compared to the acrylic co-polymer adhesive patch preparations and commercial films, adding an SSA layer markedly reduces skin stripping observed under scanning electron microscopy (SEM). Moreover, the addition of varying SSA thicknesses did not interfere with the in vitro release kinetics or drug permeation in ex vivo porcine skin. The Pf patch can be easily applied onto and removed from deep partial-thickness burn wounds on Duroc pigs. Continuous multi-day dosing of Pf by the patches (>200 μg/cm 2 /day) reduced proinflammatory biomarkers in porcine burn wounds. Pf patches produced by the manual laboratory-scale process showed excellent stability, maintaining intact physical patch properties and in vitro biological activity for up to one year under long-term (25 °C at 60% RH) and 6 months under accelerated (40 °C at 75% RH) test conditions. To manufacture our wound safe-and-extended-release patch, we present scale-up processes using a machine-driven automated roll-to-roll pilot scale coater.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2023 by the authors.

Use and reproduction: